Prognostic Impact of Paravalvular Regurgitation in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis Undergoing TAVR.
Abstract
Background
Paravalvular regurgitation (PVR) is a frequent complication after transcatheter aortic valve replacement (TAVR) and may influence clinical outcomes in patients with high-gradient aortic stenosis. However, its prognostic relevance in patients with low-flow, low-gradient aortic stenosis (LFLG-AS) undergoing TAVR remains incompletely elucidated.
Objectives
This study sought to evaluate the prognostic significance of PVR severity in patients with LFLG-AS undergoing TAVR with current-generation prostheses.
Methods
This multicenter registry-based cohort study included consecutive patients with LFLG-AS undergoing TAVR from January 2019 to December 2024 at 17 high-volume Italian centers. PVR severity was classified using a 5-class grading scheme and stratified as <2+ (none/trace or mild) or ≥2+ (mild-moderate or worse) based on separation of Kaplan-Meier curves for the primary outcome. The primary outcome was a composite of all-cause death and heart failure hospitalization up to 2 years. Propensity score-weighted Cox regression was used to estimate the independent impact of PVR severity on clinical outcomes.
Results
A total of 1,358 patients were included. Kaplan-Meier analysis showed lower event-free survival among patients with ≥2+ PVR at discharge compared with those with <2+ PVR. After propensity score weighting, PVR ≥2+ was independently associated with a higher risk of the primary endpoint (adjusted HR: 3.77; 95% CI: 2.88-4.95), as well as higher risks of all-cause death, mainly cardiovascular, and heart failure hospitalization. These findings were consistent across both classical and paradoxical LFLG-AS phenotypes.
Conclusions
In this large, real-world study of patients with LFLG-AS treated with current-generation TAVR devices, PVR ≥2+ was independently associated with worse clinical outcomes after discharge, regardless of LFLG-AS subtype.